Report: Emerging Generic Drug Markets in Europe TOC

Foreword
Executive Summary
France
Introduction
- Key Data Projections, 2007-2012
Healthcare System
- Organisation
- Health Insurance System
- Health Expenditure
  - Health Expenditure, 1995-2006 (Billion Euros)
  - Medical Consumption by Service, 2000-2006 (Billion Euros)
  - Spending Trends on Pharmaceuticals & Medical Products in the Ambulatory Sector, 1995-2005 (%)
  - Medical Consumption by Source of Funding, 1995-2006 (%)
  - Medical Consumption by Sector & Source of Funding, 2005 (%)
Healthcare Infrastructure
- Hospital Resources
  - Hospital Services, 1995-2005
  - Public Hospitals by Type, 2004
  - Private Hospitals by Type, 2005
  - Private Hospitals by Status, 2004
  - Hospital Beds & Day Places by Specialty & Sector, 2005
- Hospital Activity
  - Hospital Activity, 2001-2005
  - Hospital Activity by Specialty, 2005
  - Patient Distribution by Most Frequent Diagnostic Groups in Public & Private Hospitals, 2004
  - Inpatient Activity in Public Short-Stay Units by Major Diagnostic Groups, 2003
  - Inpatient Activity in Private Short-Stay Units by Major Diagnostic Groups, 2003
- Ambulatory Resources
  - Independent Practitioners by Type of Practice, 2002 (%)
- Medical Personnel
  - Medical Personnel, 1995-2004
  - Doctors by Specialty & Sector, 2001-2003
Pharmaceutical Market Overview
- Size
  - Summary of the French Pharmaceutical Market, 2007
- Projections
  - Market Projections, 2007-2012
- Local Manufacturers
  - Mergers & Acquisitions of French Pharmaceutical Companies, 1995-2007
  - Pharmaceutical Companies Operating in France
Generic Market
- Size
  - Reimbursable Market by Patent Status, 2002-2006 (Million Euros)
  - Reimbursable Market by Patent Status, 2002-2006 (%)
  - Change in Reimbursable Market by Patent Status, 2002-2006 (%)
  - Reimbursable Market by Patent Status, 2002-2006 (Million Units)
  - Reimbursable Market by Patent Status, 2002-2006 (%)
  - Change in Reimbursable Market by Patent Status, 2003-2006 (%)
  - Reimbursable Market by Substitution, 2006
  - Substitutable Market by Reimbursement Status, 2005-2006 (Million Euros)
  - Subtitutable Market by Reimbursement Status, 2005-2006 (%)
- Projections
  - Projected Generics Market, 2007-2012 (US$ Billion)
- Outlook
  - Outcomes of the New Reference Pricing System
  - Increasing Prescribing of Generics
  - Generic Drugs to Reduce Health Expenditure by 912 Million Euros in 2006
    - Trends in Generic Drug Consumption, 2003-2006
  - France Transposes EU Pharmaceutical Directive
  - Pharmacists Associations Agree New Generics Target for 2007
    - Generics Penetration Objectives by Volume, 2006
    - Generics Penetration Objectives by Volume, 2007
- SWOT
  - SWOT Analysis of the French Generics Market, 2007
- Trade Association
  - Members of GEMME, 2007
- Domestic Production
  - Leading French Generic Producers, 2005-2006 (%)
- Local Manufacturers
  - Arrow Génériques
  - Biogaran
  - Bouchara-Recordati
  - EG-Labo
    - EG-Labo' s Sales, 2002-2006 (Million Euros)
    - EG-Labo' s Sales as % of Stada' s Sales, 2002-2006
- Merck Génériques
  - Merck Génériques' Financial Indicators, 2003-2006
- Ranbaxy
  - Ranbaxy Pharmacie Génériques' Sales, 2004-2006 (US$ Million)
- ratiopharm
  - ratiopharm France' s Sales, 2004-2006 (Million Euros)
- Sandoz
  - Sandoz France' s Sales, 2001-2006 (Million Euros)
- Teva
- Winthrop
- Wockhardt
- Zydus France
  - Zydus France' s Sales, 2003-2005
Regulatory Environment
- Registration
- Pricing & reimbursement
  - Pricing
  - Pricing of Reimbursable Medicines in the Retail Pharmacy Market
  - Price Revisions
  - Pricing Activity
    - Drug Pricing Applications Submitted by Type, 2006
    - Average Number of Days Taken to Process First-Time Registrations, 2006
  - Pharmacy Margins
  - Reference Pricing (TFR)
  - Pricing of Hospital Medicines
  - Reimbursement
    - Distribution of the Pharmaceutical Market According to Reimbursement Rate, 2006
- Intellectual Property
  - Leading Active Ingredients Coming off Patent, 2005-2007
- Supplementary Protection Certificates
Generics in the French PPI Market
- PPIs on the French market, 2007
- Reimbursable Sales of PPPIs (Régime Générale), 2002-2006 (Million Euros)
- Reimbursable Sales of PPPIs (Régime Générale), 2002-2006 (%)
- Reimbursable Sales of PPPIs (Régime Générale), 2002-2006 (Million Units)
- Reimbursable Sales of PPPIs (Régime Générale), 2002-2006 (%)
- Reimbursable Sales of PPPIs (Régime Générale), 2002-2006 (Average Unit Price, Euros)
- Reimbursable Sales of PPIs by Patent Status (Régime Générale), 2004-2006 (Million Euros)
- Reimbursable Sales of PPIs by Patent Status (Régime Générale), 2004-2006 (Million Units)
Omeprazole and esomeprazole
- Omeprazole Sales Data (Régime Générale), 2004-2006 (Million Euros)
- Omeprazole Sales Data (Régime Générale), 2004-2006 (Million Units)
- Esomeprazole & Omeprazole Sales Data (Régime Générale), 2002-2006 (Million Euros)
- Esomepraole & Omeprazole Sales Data (Régime Générale), 2002-2006 (Million Units)
Generics in the French Statins Market
- Statins on the French Market, 2007
- Reimbursable Sales of Statins (Régime Générale), 2002-2006 (Million Euros)
- Reimbursable Sales of Statins (Régime Générale), 2002-2006 (%)
- Reimbursable Sales of Statins (Régime Générale), 2002-2006 (Million Units)
- Reimbursable Sales of Statins (Régime Générale), 2002-2006 (%)
- Average Unit Price of Statins (Régime Générale), 2002-2006 (Euros)
- Reimbursable Sales of Statins & Ezetimibe (Régime Générale), 2002-2006 (Million Euros)
- Reimbursable Sales of Statins by Patent Status (Régime Générale), 2005-2006 (Million Euros)
- Reimbursable Sales of Statins by Patent Status (Régime Générale), 2005-2006 (Million Units)
Pravastatin
- Pravastatin Sales Data (Régime Générale), 2006
Simvastatin
- Simvastatin Sales Data (Régime Générale), 2005-2006 (000s Euros)
- Simvastatin Sales Data (Régime Générale), 2005-2006 (000s Units)
- Simvastatin + Ezetimibe Sales Data (Régime Générale), 2005-2006 (Million Euros)
- Simvastatin + Ezetimibe Sales Data (Régime Générale), 2005-2006 (Million Units)
Directory
- Government Organisations
- Generic Trade Association
- Generic Manufacturers
Italy
Introduction
- Key Data Projections, 2007-2012
Healthcare System
- Organisation
- Health Expenditure
- Health Expenditure, 2000-2006 (Million Euros)
- Public Health Expenditure by Type, 2000-2006 (Million Euros)
- Public Health Expenditure by Region & Type, 2006 (Million Euros)
- Private Health Expenditure by Region, 1998-2003 (Million Euros)
Healthcare Infrastructure
- Hospital Resources
  - Inpatient Institutions by Type, 2000-2005
  - Inpatient Institutions by Region, 2000-2005
  - Hospital Beds by Type, 2005
  - Hospital Beds, 1997-2005
  - Hospital Beds by Region, 2005
- Hospital Activity
  - Hospital Activity, 2000-2004
  - Hospital Activity by Sector, 2004
  - Public Acute Hospital Activity by Region, 2004
  - Private Accredited Acute Hospital Activity by Region, 2004
  - Hospital Activity by Diagnosis Group, 2004
- Ambulatory Resources
  - Guardia Medica Points by Region, 2005
  - Ambulatory & Other Facilities, 2005
  - Ambulatory & Other Facilities by Type of Service, 2000-2005
- Ambulatory Activity
  - Clinical, Laboratory & Diagnostic Procedures, 2005
- Medical Personnel
  - Registered Doctors by Region, 2006
  - SSN Personnel, 2000-2005
Pharmaceutical Market Overview
- Size
  - Summary of the Italian Pharmaceutical Market, 2007
  - Number of Pharmaceutical Products & Presentations, 2000-2006
  - Number of SSN Pharmaceutical Products & Presentations, 2000-2007
- Projections
  - Market Projections, 2007-2012
- Local Manufacturers
Generic Market
- Size
  - Net SSN Sales by Patent Status, 2002-2006 (Million Euros)
  - Net SSN Sales by Patent Status, 2002-2006 (%)
  - Change in Net SSN Sales by Patent Status, 2003-2006 (%)
  - Generics Sales as % of Net SSN Sales by Region, 2002-2006
  - Per Capita Net SSN Generics Expenditure by Region, 2002-2006 (Euros)
  - Net SSN Generics Sales by Region, 2002-2006 (DDD/1,000 Population)
  - Generics Sales as % of Net SSN Sales by Region, 2002-2006 (DDD/1,000 Population)
  - Gross SSN Generics Sales by Leading Active Ingredient, 2006 (Million Euros)
  - Gross SSN Generics Sales by Leading Active Ingredient, 2006 (DDD)
- Projections
  - Projected Unbranded Generic Market, 2007-2012
- Outlook
  - SWOT Analysis of the Italian Generics Market, 2007
- Domestic Production
  - Leading Italian Generic Producers, 2007
- Trade Association
  - ASSOGENERICI
    - Members of ASSOGENERICI, 2007
- Local Manufacturers
  - Angenerico
    - Angelini' s Pharmaceutical Companies, 2006
  - DOC Generici
  - Eurogenerici
    - Eurogenerici' s Sales, 2002-2006 (Million Euros)
    - Eurogenerici' s Sales, 2002-2006 (%)
    - Eugenerici' s Sales as % of Stada' s Sales, 2002-2006 (%)
  - Hexan
  - Merck Generics Italia
    - Merck Generics Italia' s Sales, 2004-2006 (Million Euros)
  - Pliva Pharma
    - Pliva Italia' s Sales, 2003-2005 (US$ Million)
  - Ranbaxy
  - ratiopharm Italia
  - Sandoz
    - Sandoz' s Italian Sales within the Novartis Group, 2004-2005 (Million Euros)
  - Teva Pharma Italia
    - Teva Pharma Italia' s Production Capabilities, 2006
Regulatory Environment
- Pricing & Reimbursement
  - EU Directive on the Transparency of Pricing & Reimbursement
  - Reimbursement
- Intellectual Property
  - National Supplementary Protection Certificate
    - Leading Active Ingredients with Patents Close to Expiry, 2007
- Directory
  - Government Organisations
  - Generic Trade Associations
  - Generic Manufacturers
Portugal
Introduction
- Key Data Projections, 2007-2012
Healthcare System
- Organisation
  - Organic Health Law No. 10/1993
    - Health Regions, 1993
  - Decree Law No. 257/2001
- Health Expenditure
  - Projected Health Expenditure, 2006-2012
  - Health Expenditure, 2000-2005 (Million Euros)
- Healthcare Infrastructure
  - Hospital Resources
    - Public & Private Hospitals, 1990-2005
    - Public & Private Hospitals by Region, 2005
    - General & Specialty Hospitals by Type, 2005
    - Hospital Beds & Operating Rooms, 1990-2005
  - Hospital Activity
    - Hospital Admissions, 1990-2005
    - Hospital Admissions by Region, 2005
    - Hospital Admissions by Hospital Type, 2005
    - Admissions, Discharges & Patient Days by Hospital Specialty, 2005
    - Hospital Consultations by Specialty, 1990-2005 (000s)
    - Hospital Consultations by Specialty & Region, 2005 (000s)
    - Hospitals Diagnostic Procedures, 2001-2005
    - Public & Private Hospitals Therapeutic Procedures, 2005
  - Outpatient Resources
    - Outpatient Health Centres, Sub-Centres & Beds, 1990-2005
  - Outpatient Activity
    - Outpatient Admissions & Days, 1990-2005
    - Outpatient Admissions & Days by Region, 2005
    - Outpatient Consultations by Specialty, 1990-2005 (000s)
  - Medical Personnel
Pharmaceutical Market Overview
- Size
  - Summary of the Portuguese Pharmaceutical Market at Retail Prices, 2007
- Projections
  - Market Projections, 2007-2012
- Local manufacturers
  - INFARMED' s Listed National Manufacturers, 2007
Generic Market
- Size
  - Generics Pharmacy Sales by Value & Volume, 2003-2006
  - Generics Pharmacy Sales by Month, 2003-2006 (Million Euros)
  - Generics Pharmacy Sales by Month, 2003-2006 (000 Units)
  - Generics as a Percentage of the Pharmacy Sector by Volume, 2003-2006
  - Generics Pharmacy Sales by Therapeutic Area, 2006 (Million Euros)
  - Generics Pharmacy Sales by Therapeutic Area, 2006 (Million Units)
  - Generics Pharmacy Sales by Leading Active Ingredient, 2006 (Million Euros)
  - Generics Pharmacy Sales by Leading Active Ingredient, 2006 (Million Units)
- Projections
  - Projected Generics Market, 2007-2012
- Outlook
- SWOT
  - SWOT Analysis of the Portuguese Generics Market, 2007
- Trade Association
  - APOGEN
    - Members of APOGEN, 2007
- Domestic Production
  - Leading Portuguese Generic Producers, 2007
  - Leading Generic Producers in the Pharmacy Sector, 2005 (%)
- Local Manufacturers
  - Actavis
  - Alter
  - Bluepharma
  - Ciclum Farma
    - Ciclum Farma' s Sales, 2005-2006 (Million Euros)
  - Generis
  - Germed
  - Hovione
  - Labesfal
  - Medinfar
  - Merck Genéricos
  - Ranbaxy
  - ratiopharm
  - Sandoz
- Tecnimede
  - Tecnimede' s Financial Indicators, 2003-2007
  - Tecnimede' s Employees by Company, 2007
- ToLife
- Winthrop
Regulatory Environment
- Registration
  - Market Authorisations of Generic Medicines in the Pharmacy Sector, 2004-2007
  - Change in Market Authorisations of Generic Medicines in the Pharmacy Sector, 2005-2007 (%)
  - Market Authorisations of Generic Presentations, 2004-2007
  - Change in Market Authorisations of Generic Presentations, 2005-2007 (%)
- Pricing & Reimbursement
  - Generics Presentations by Reimbursement Status & Price Range, 2005
- Reimbursement
- EU Directive on the Transparency of Pricing & Reimbursement
  - Reimbursements
    - Generic Medicines by Reimbursement & Prescription Status, 2005
    - Generic Presentations by Reimbursement & Prescription Status, 2005
    - Generic Medicines & Presentations by Reimbursement Level, 2005
    - Generic Presentations by Reimbursement Level & Therapeutic Group, 2005
- Intellectual Property
  - European Supplementary Protection Certificate
  - Organon Commences Tibolone Patent Infringement Litigation in Portugal
Directory
- Government Organisations
- Generic Trade Association
- Generic Manufacturers
Spain
Introduction
- Key Data, 2007-2012
Healthcare System
- Organisation
  - Health Cohesion & Quality Law
- Health Expenditure
  - Projected Health Expenditure, 2007-2012
- Healthcare Infrastructure
  - Hospital Resources
    - Hospitals by Provision & Region, 2006
    - Hospitals by Provision & Specialty, 2006
    - Hospitals, 1985-2006
    - Hospital Beds by Provision & Region, 2006
    - Hospital Beds by Provision & Specialty, 2006
    - Hospital Beds, 1985-2006
  - Hospital Activity
    - Hospital Activity by Provision, 2005
    - Hospital Activity by Specialty, 2005
    - Hospital Discharges by Hospital Type & Specialty, 2005
    - Hospital Discharges, 1994-2005
  - Ambulatory Resources
    - Primary Care Consultations, 1994 & 2003
  - Medical Personnel
    - Registered Medical Personnel, 2000-2006
    - Practising Medical Personnel, 2006
Pharmaceutical Market Overview
- Size
  - Summary of the Spanish Pharmaceutical Market, 2007
- Projections
  - Market Projections, 2007-2012
- Local Manufacturers
  - Leading Pharmaceutical Companies in Spain, 2006
Generic Market
- Size
  - Generics Pharmacy Sales by Value & Volume, 2002-2006
  - Pharmacy Sales Value & Volume by Patent Status, 2006
  - SNS Pharmaceutical Sales by Patent Status, 2000-2005 (Million Euros)
  - SNS Pharmaceutical Sales by Patent Status, 2000-2005 (%)
  - Change in SNS Pharmaceutical Sales by Patent Status, 2000-2005 (%)
  - SNS Pharmaceutical Sales by Patent Status, 2000-2005 (Million Units)
  - SNS Pharmaceutical Sales by Patent Status, 2000-2005 (%)
  - Change in SNS Pharmaceutical Sales by Patent Status, 2000-2005 (%)
  - SNS Prescription Cost by Patent Status, 2000-2005 (Euros)
- Projections
  - Projected Generics Market, 2007-2012
- Outlook
  - Biosimilars' Substitution, Not a Viable Option in Spain
  - Regional INN Prescribing
    - Regional Generic Penetration
  - The II Iberian Simposium on Generics
    - Findings of the Study on Generics Perception, October 2005
- SWOT
  - SWOT Analysis of the Spanish Generics Market, 2007
- Trade Association
  - AESEG
    - Members of AESEG, 2007
- Local Manufacturers
  - Leading Spanish Generic Producers, 2007
  - Companies with Generics in the Market, January 2007
  - Number of Companies with Generics in the SNS Market, 2000-2006
  - Companies by Number of Generics in the SNS Market, 2000-2006
  - Companies by Number of Generics in the SNS Market, 2006
- Adamed
- Alter
  - Alter' s Financial Indicators, 2005-2006
- Barr
- Cantabria Pharma
- Cinfa
- Combino Pharm
- DOMAC
- Dr Reddy' s
- Kern Pharma
- Mabo-Farma
- Merck
- Normon
  - Normon' s Financial Indicators, 1997-2006
- Pharmagenus
- Ranbaxy
  - Ranbaxy Spain' s Sales, 2004-2006 (US$ Million)
- ratiopharm
- Sandoz
  - Novartis España' s Sales by Division, 2000-2005 (Million Euros)
  - Novartis España' s Employees by Division, 2000-2005
  - Sandoz' s Leading Generics, 2005
- Stada
  - Laboratorio Stada' s Sales, 2003-2006 (Million Euros)
- Teva
Regulatory Environment
- Registration
  - Active Ingredients & Presentations of Generic Medicines, 2000-2006
  - Presentations by Patent Status, 2006
  - Presentations of Generic Medicines by Administration Type, 2000-2006
  - Presentations of Generic Medicines by Administration Type, 2000-2006 (%)
  - Active Ingredients & Presentations of Generic Medicines by Therapeutic Area, 2006
  - Active Ingredients with the Highest Number of Generic Presentations, 2000-2006
  - Active Ingredients with the Highest Number of Presentations by Patent Status, 2006
- Pricing & Reimbursement
  - Co-Payments
    - Co-Payments, 2006
  - RPS Analysis
    - SNS Pharmaceutical Sales by the Reference Price System, 2005 (%)
  - Generic Pricing
    - Retail Prices of Presentations of Generic Medicines by Type, 2002-2006 (Euros)
  - Intellectual property
    - European Supplementary Protection Certificate
- Directory
  - Government Organisations
  - Generic Trade Association
  - Generic Manufacturers

Emerging Generic Drug Markets in Europe

Table of Contents